Detailed Information

Cited 60 time in webofscience Cited 66 time in scopus
Metadata Downloads

Anti-integrin therapy for inflammatory bowel disease

Full metadata record
DC FieldValueLanguage
dc.contributor.authorPark, Sung Chul-
dc.contributor.authorJeen, Yoon Tae-
dc.date.available2020-11-02T07:40:55Z-
dc.date.created2020-10-15-
dc.date.issued2018-05-07-
dc.identifier.issn1007-9327-
dc.identifier.urihttps://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/3552-
dc.description.abstractIn inflammatory bowel disease (IBD), tumor necrosis factor plays an important role in mediating inflammation, but several other pathways are also involved in eliciting an inflammatory response. One such pathway is the invasion of the intestinal mucosa by leukocytes. Leukocytes within the systemic circulation move to sites of inflammation, and blocking this pathway could be an important treatment strategy for IBD. Anti-integrin therapy blocks the action of integrin on the surface of circulating immune cells and endothelial cell adhesion molecules, thereby inhibiting the interactions between leukocytes and intestinal blood vessels. Natalizumab, which acts on alpha 4-integrin, was the first such drug to be approved for Crohn's disease, but its use is limited due to the risk of progressive multifocal leukoencephalopathy. Vedolizumab produces few systemic adverse effects because it acts on gut-trophic alpha 4 beta 7 integrin, and has been approved and is being used to treat IBD. Currently, several anti-integrin drugs, including etrolizumab, which acts on beta 7-integrin, and PF-00547569, which targets mucosal addressin cell adhesion molecule-1, are undergoing clinical trials and the results are being closely watched.-
dc.language영어-
dc.language.isoen-
dc.publisherBAISHIDENG PUBLISHING GROUP INC-
dc.subjectVEDOLIZUMAB INDUCTION THERAPY-
dc.subjectACTIVE CROHNS-DISEASE-
dc.subjectMAINTENANCE THERAPY-
dc.subjectULCERATIVE-COLITIS-
dc.subjectENDOTHELIAL-CELLS-
dc.subjectDOUBLE-BLIND-
dc.subjectEFFICACY-
dc.subjectNATALIZUMAB-
dc.subjectANTAGONIST-
dc.subjectEXPRESSION-
dc.titleAnti-integrin therapy for inflammatory bowel disease-
dc.typeArticle-
dc.contributor.affiliatedAuthorJeen, Yoon Tae-
dc.identifier.doi10.3748/wjg.v24.i17.1868-
dc.identifier.scopusid2-s2.0-85047077145-
dc.identifier.wosid000431457900004-
dc.identifier.bibliographicCitationWORLD JOURNAL OF GASTROENTEROLOGY, v.24, no.17, pp.1868 - 1880-
dc.relation.isPartOfWORLD JOURNAL OF GASTROENTEROLOGY-
dc.citation.titleWORLD JOURNAL OF GASTROENTEROLOGY-
dc.citation.volume24-
dc.citation.number17-
dc.citation.startPage1868-
dc.citation.endPage1880-
dc.type.rimsART-
dc.type.docTypeReview-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaGastroenterology & Hepatology-
dc.relation.journalWebOfScienceCategoryGastroenterology & Hepatology-
dc.subject.keywordPlusVEDOLIZUMAB INDUCTION THERAPY-
dc.subject.keywordPlusACTIVE CROHNS-DISEASE-
dc.subject.keywordPlusMAINTENANCE THERAPY-
dc.subject.keywordPlusULCERATIVE-COLITIS-
dc.subject.keywordPlusENDOTHELIAL-CELLS-
dc.subject.keywordPlusDOUBLE-BLIND-
dc.subject.keywordPlusEFFICACY-
dc.subject.keywordPlusNATALIZUMAB-
dc.subject.keywordPlusANTAGONIST-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordAuthorIntegrin-
dc.subject.keywordAuthorUlcerative colitis-
dc.subject.keywordAuthorCrohn&apos-
dc.subject.keywordAuthors disease-
dc.subject.keywordAuthorNatalizumab-
dc.subject.keywordAuthorAbrilumab-
dc.subject.keywordAuthorEtrolizumab-
dc.subject.keywordAuthorPF-00547659-
dc.subject.keywordAuthorInflammatory bowel disease-
dc.subject.keywordAuthorAJM300-
dc.subject.keywordAuthorVedolizumab-
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Jeen, Yoon Tae photo

Jeen, Yoon Tae
Anam Hospital (Department of Gastroenterology and Hepatology, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE